secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2025-12-30T23:59:59+00:00
Accession:  0001493152-25-029510
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 7.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed announces 1-for-30 reverse stock split effective Jan 2, 2026 to regain Nasdaq compliance
--------------------------------------------------------------------------------

- 1-for-30 reverse split effective Jan 2, 2026; authorized shares reduced from 250M to 25M.
- Split intended to regain compliance with Nasdaq $1.00 minimum bid price requirement.
- No fractional shares; all fractional shares rounded up to nearest whole share.
- CUSIP changes to 70387R 502; ticker PAVM unchanged.
- Stockholder approved at Dec 5 special meeting; board set ratio on Dec 8, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315225029510/0001493152-25-029510-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315225029510/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-029510

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer